Cargando…

Astragaloside IV improves renal function and fibrosis via inhibition of miR-21-induced podocyte dedifferentiation and mesangial cell activation in diabetic mice

BACKGROUND: Podocyte dedifferentiation and mesangial cell (MC) activation play an important role in many glomerular diseases associated with fibrosis. MicroRNA-21 (miR-21) is closely linked to renal fibrosis, but it is unknown whether and how miR-21 promotes podocyte dedifferentiation and MC activat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Xiaolei, Gao, Yanbin, Tian, Nianxiu, Zou, Dawei, Shi, Yimin, Zhang, Nan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6084069/ https://www.ncbi.nlm.nih.gov/pubmed/30122901 http://dx.doi.org/10.2147/DDDT.S170840

Ejemplares similares

Astragaloside IV inhibits glucose-induced epithelial-mesenchymal transition of podocytes through autophagy enhancement via the SIRT–NF-κB p65 axis
por: Wang, Xiaolei, et al.
Publicado: (2019)

Astragaloside IV represses high glucose-induced mesangial cells activation by enhancing autophagy via SIRT1 deacetylation of NF-κB p65 subunit
por: Wang, Xiaolei, et al.
Publicado: (2018)

Emodin mitigates podocytes apoptosis induced by endoplasmic reticulum stress through the inhibition of the PERK pathway in diabetic nephropathy
por: Tian, Nianxiu, et al.
Publicado: (2018)

Effect of Tongxinluo on Podocyte Apoptosis via Inhibition of Oxidative Stress and P38 Pathway in Diabetic Rats
por: Cui, Fangqiang, et al.
Publicado: (2016)

Astragaloside IV inhibits excessive mesangial cell proliferation and renal fibrosis caused by diabetic nephropathy via modulation of the TGF-β1/Smad/miR-192 signaling pathway
por: Mao, Qian, et al.
Publicado: (2019)

Exosomes from high glucose-treated glomerular endothelial cells trigger the epithelial-mesenchymal transition and dysfunction of podocytes
por: Wu, Xiaoming, et al.
Publicado: (2017)

Astragaloside IV, a Novel Antioxidant, Prevents Glucose-Induced Podocyte Apoptosis In Vitro and In Vivo
por: Gui, Dingkun, et al.
Publicado: (2012)

Astragaloside IV inhibits palmitic acid-induced apoptosis through regulation of calcium homeostasis in mice podocytes
por: Zang, Yingjun, et al.
Publicado: (2021)

Protective Effect of Astragaloside IV against Cadmium-Induced Damage on Mouse Renal Podocytes (MPC5)
por: Gong, Pin, et al.
Publicado: (2023)

Evaluation of astragaloside IV in hepatic fibrosis: A meta-analysis
por: Han, Zhongying, et al.
Publicado: (2021)

Anticancer effects and mechanisms of astragaloside-IV
por: Zhou, Liangxing, et al.
Publicado: (2022)

Mesangial Cell–Derived Exosomal miR-4455 Induces Podocyte Injury in IgA Nephropathy by Targeting ULK2
por: Yu, Mengjie, et al.
Publicado: (2022)

Astragaloside IV attenuates hypoxia/reoxygenation injury-induced apoptosis of type II alveolar epithelial cells through miR-21-5p
por: Li, Hang, et al.
Publicado: (2021)

Tangshenning Attenuates High Glucose-Induced Podocyte Injury via Restoring Autophagy Activity through Inhibiting mTORC1 Activation
por: Xu, Jiayi, et al.
Publicado: (2022)

Astragaloside IV/lncRNA-TUG1/TRAF5 signaling pathway participates in podocyte apoptosis of diabetic nephropathy rats
por: Lei, Xiao, et al.
Publicado: (2018)

Astragaloside IV protects human cardiomyocytes from hypoxia/reoxygenation injury by regulating miR-101a
por: Wu, Yang, et al.
Publicado: (2020)

Protective effect of astragalosides from Radix Astragali on adriamycin-induced podocyte injury
por: Sai, Yi-Pa, et al.
Publicado: (2018)

Effects of Astragaloside IV on heart failure in rats
por: Zhao, Zhuanyou, et al.
Publicado: (2009)

Effects of astragaloside IV on the pharmacokinetics of omeprazole in rats
por: Liu, Wei, et al.
Publicado: (2019)

Astragaloside IV, as a potential anticancer agent
por: Xia, Dongqin, et al.
Publicado: (2023)

Pharmacological Effects of Astragaloside IV: A Review
por: Liang, Yutong, et al.
Publicado: (2023)

Podocyte Dedifferentiation: A Specialized Process for a Specialized Cell
por: May, Carl James, et al.
Publicado: (2014)

Accelerated Bone Regeneration by Astragaloside IV through Stimulating the Coupling of Osteogenesis and Angiogenesis
por: Wang, Feng, et al.
Publicado: (2021)

Astragaloside IV synergizes with ferulic acid to inhibit renal tubulointerstitial fibrosis in rats with obstructive nephropathy
por: Meng, LQ, et al.
Publicado: (2011)

Astragaloside IV Improves Bleomycin-Induced Pulmonary Fibrosis in Rats by Attenuating Extracellular Matrix Deposition
por: Li, Liu-Cheng, et al.
Publicado: (2017)

Astragaloside IV protects retinal pigment epithelial cells from apoptosis by upregulating miR-128 expression in diabetic rats
por: Wang, Tao, et al.
Publicado: (2020)

Astragaloside II Ameliorated Podocyte Injury and Mitochondrial Dysfunction in Streptozotocin-Induced Diabetic Rats
por: Su, Jun, et al.
Publicado: (2021)

The mechanism of astragaloside IV promoting sciatic nerve regeneration
por: Zhang, Xiaohong, et al.
Publicado: (2013)

Astragaloside IV: An Effective Drug for the Treatment of Cardiovascular Diseases
por: Tan, Yu-Qing, et al.
Publicado: (2020)

Molecular mechanisms of astragaloside-IV in cancer therapy (Review)
por: Chen, Tianqi, et al.
Publicado: (2021)

Roles and Mechanisms of Astragaloside IV in Combating Neuronal Aging
por: Zaman, Qumar, et al.
Publicado: (2022)

Research progress on the mechanism of astragaloside IV in the treatment of asthma
por: Yuan, Fanyi, et al.
Publicado: (2023)

Astragaloside IV Attenuates High-Glucose-Induced Impairment in Diabetic Nephropathy by Increasing Klotho Expression via the NF-κB/NLRP3 Axis
por: He, Jiaxin, et al.
Publicado: (2023)

Astragaloside IV inhibits oxidized low-density lipoprotein-induced endothelial damage via upregulation of miR-140-3p
por: Qian, Weibin, et al.
Publicado: (2019)

Astragaloside IV inhibits oxidized low-density lipoprotein-induced endothelial damage via upregulation of miR-140-3p
por: Qian, Weibin, et al.
Publicado: (2023)

Astragaloside IV ameliorates peritoneal fibrosis by promoting PGC‐1α to reduce apoptosis in vitro and in vivo
por: Xie, Mingxia, et al.
Publicado: (2023)

Calpain-10 drives podocyte apoptosis and renal injury in diabetic nephropathy
por: Wang, Tao, et al.
Publicado: (2019)

Redox Signaling in Diabetic Nephropathy: Hypertrophy versus Death Choices in Mesangial Cells and Podocytes
por: Manda, Gina, et al.
Publicado: (2015)

Editorial: Interactions Between Podocytes, Mesangial Cells, and Glomerular Endothelial Cells in Glomerular Diseases
por: Imig, John D., et al.
Publicado: (2022)

Inhibition of miRNA-1-Mediated Inflammation and Autophagy by Astragaloside IV Improves Lipopolysaccharide-Induced Cardiac Dysfunction in Rats
por: Wang, Qiuning, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qj3ck9n5k459udcqqvsp99f9f8